Report cover image

Global Frovatriptan Succinate Tablets Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 108 Pages
SKU # APRC20339547

Description

Summary

According to APO Research, The global Frovatriptan Succinate Tablets market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Frovatriptan Succinate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Frovatriptan Succinate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Frovatriptan Succinate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Frovatriptan Succinate Tablets include Clydesdale Pharma, Glenmark Pharmaceuticals, Ingenus Pharmaceutical, Ligand Pharmaceuticals, Menarini, Paladin Pharma, Ulagaylar Pharma, Mylan and Teva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Frovatriptan Succinate Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Frovatriptan Succinate Tablets.
The Frovatriptan Succinate Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Frovatriptan Succinate Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Frovatriptan Succinate Tablets Segment by Company

Clydesdale Pharma
Glenmark Pharmaceuticals
Ingenus Pharmaceutical
Ligand Pharmaceuticals
Menarini
Paladin Pharma
Ulagaylar Pharma
Mylan
Teva
Endo Pharmaceuticals
Chia Tai Tianqing
Frovatriptan Succinate Tablets Segment by Type

Original Drug
Generic Drug
Frovatriptan Succinate Tablets Segment by Application

Original Drug
Generic Drug
Frovatriptan Succinate Tablets Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Frovatriptan Succinate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Frovatriptan Succinate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Frovatriptan Succinate Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Frovatriptan Succinate Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Frovatriptan Succinate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

108 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Frovatriptan Succinate Tablets Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Frovatriptan Succinate Tablets Sales Estimates and Forecasts (2020-2031)
1.3 Frovatriptan Succinate Tablets Market by Type
1.3.1 Original Drug
1.3.2 Generic Drug
1.4 Global Frovatriptan Succinate Tablets Market Size by Type
1.4.1 Global Frovatriptan Succinate Tablets Market Size Overview by Type (2020-2031)
1.4.2 Global Frovatriptan Succinate Tablets Historic Market Size Review by Type (2020-2025)
1.4.3 Global Frovatriptan Succinate Tablets Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Frovatriptan Succinate Tablets Sales Breakdown by Type (2020-2025)
1.5.2 Europe Frovatriptan Succinate Tablets Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Frovatriptan Succinate Tablets Sales Breakdown by Type (2020-2025)
1.5.4 South America Frovatriptan Succinate Tablets Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Frovatriptan Succinate Tablets Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Frovatriptan Succinate Tablets Industry Trends
2.2 Frovatriptan Succinate Tablets Industry Drivers
2.3 Frovatriptan Succinate Tablets Industry Opportunities and Challenges
2.4 Frovatriptan Succinate Tablets Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Frovatriptan Succinate Tablets Revenue (2020-2025)
3.2 Global Top Players by Frovatriptan Succinate Tablets Sales (2020-2025)
3.3 Global Top Players by Frovatriptan Succinate Tablets Price (2020-2025)
3.4 Global Frovatriptan Succinate Tablets Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Frovatriptan Succinate Tablets Major Company Production Sites & Headquarters
3.6 Global Frovatriptan Succinate Tablets Company, Product Type & Application
3.7 Global Frovatriptan Succinate Tablets Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Frovatriptan Succinate Tablets Market CR5 and HHI
3.8.2 Global Top 5 and 10 Frovatriptan Succinate Tablets Players Market Share by Revenue in 2024
3.8.3 2023 Frovatriptan Succinate Tablets Tier 1, Tier 2, and Tier 3
4 Frovatriptan Succinate Tablets Regional Status and Outlook
4.1 Global Frovatriptan Succinate Tablets Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Frovatriptan Succinate Tablets Historic Market Size by Region
4.2.1 Global Frovatriptan Succinate Tablets Sales in Volume by Region (2020-2025)
4.2.2 Global Frovatriptan Succinate Tablets Sales in Value by Region (2020-2025)
4.2.3 Global Frovatriptan Succinate Tablets Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Frovatriptan Succinate Tablets Forecasted Market Size by Region
4.3.1 Global Frovatriptan Succinate Tablets Sales in Volume by Region (2026-2031)
4.3.2 Global Frovatriptan Succinate Tablets Sales in Value by Region (2026-2031)
4.3.3 Global Frovatriptan Succinate Tablets Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Frovatriptan Succinate Tablets by Application
5.1 Frovatriptan Succinate Tablets Market by Application
5.1.1 Original Drug
5.1.2 Generic Drug
5.2 Global Frovatriptan Succinate Tablets Market Size by Application
5.2.1 Global Frovatriptan Succinate Tablets Market Size Overview by Application (2020-2031)
5.2.2 Global Frovatriptan Succinate Tablets Historic Market Size Review by Application (2020-2025)
5.2.3 Global Frovatriptan Succinate Tablets Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Frovatriptan Succinate Tablets Sales Breakdown by Application (2020-2025)
5.3.2 Europe Frovatriptan Succinate Tablets Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Frovatriptan Succinate Tablets Sales Breakdown by Application (2020-2025)
5.3.4 South America Frovatriptan Succinate Tablets Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Frovatriptan Succinate Tablets Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Clydesdale Pharma
6.1.1 Clydesdale Pharma Comapny Information
6.1.2 Clydesdale Pharma Business Overview
6.1.3 Clydesdale Pharma Frovatriptan Succinate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Clydesdale Pharma Frovatriptan Succinate Tablets Product Portfolio
6.1.5 Clydesdale Pharma Recent Developments
6.2 Glenmark Pharmaceuticals
6.2.1 Glenmark Pharmaceuticals Comapny Information
6.2.2 Glenmark Pharmaceuticals Business Overview
6.2.3 Glenmark Pharmaceuticals Frovatriptan Succinate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Glenmark Pharmaceuticals Frovatriptan Succinate Tablets Product Portfolio
6.2.5 Glenmark Pharmaceuticals Recent Developments
6.3 Ingenus Pharmaceutical
6.3.1 Ingenus Pharmaceutical Comapny Information
6.3.2 Ingenus Pharmaceutical Business Overview
6.3.3 Ingenus Pharmaceutical Frovatriptan Succinate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ingenus Pharmaceutical Frovatriptan Succinate Tablets Product Portfolio
6.3.5 Ingenus Pharmaceutical Recent Developments
6.4 Ligand Pharmaceuticals
6.4.1 Ligand Pharmaceuticals Comapny Information
6.4.2 Ligand Pharmaceuticals Business Overview
6.4.3 Ligand Pharmaceuticals Frovatriptan Succinate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ligand Pharmaceuticals Frovatriptan Succinate Tablets Product Portfolio
6.4.5 Ligand Pharmaceuticals Recent Developments
6.5 Menarini
6.5.1 Menarini Comapny Information
6.5.2 Menarini Business Overview
6.5.3 Menarini Frovatriptan Succinate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Menarini Frovatriptan Succinate Tablets Product Portfolio
6.5.5 Menarini Recent Developments
6.6 Paladin Pharma
6.6.1 Paladin Pharma Comapny Information
6.6.2 Paladin Pharma Business Overview
6.6.3 Paladin Pharma Frovatriptan Succinate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Paladin Pharma Frovatriptan Succinate Tablets Product Portfolio
6.6.5 Paladin Pharma Recent Developments
6.7 Ulagaylar Pharma
6.7.1 Ulagaylar Pharma Comapny Information
6.7.2 Ulagaylar Pharma Business Overview
6.7.3 Ulagaylar Pharma Frovatriptan Succinate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ulagaylar Pharma Frovatriptan Succinate Tablets Product Portfolio
6.7.5 Ulagaylar Pharma Recent Developments
6.8 Mylan
6.8.1 Mylan Comapny Information
6.8.2 Mylan Business Overview
6.8.3 Mylan Frovatriptan Succinate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mylan Frovatriptan Succinate Tablets Product Portfolio
6.8.5 Mylan Recent Developments
6.9 Teva
6.9.1 Teva Comapny Information
6.9.2 Teva Business Overview
6.9.3 Teva Frovatriptan Succinate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Teva Frovatriptan Succinate Tablets Product Portfolio
6.9.5 Teva Recent Developments
6.10 Endo Pharmaceuticals
6.10.1 Endo Pharmaceuticals Comapny Information
6.10.2 Endo Pharmaceuticals Business Overview
6.10.3 Endo Pharmaceuticals Frovatriptan Succinate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Endo Pharmaceuticals Frovatriptan Succinate Tablets Product Portfolio
6.10.5 Endo Pharmaceuticals Recent Developments
6.11 Chia Tai Tianqing
6.11.1 Chia Tai Tianqing Comapny Information
6.11.2 Chia Tai Tianqing Business Overview
6.11.3 Chia Tai Tianqing Frovatriptan Succinate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Chia Tai Tianqing Frovatriptan Succinate Tablets Product Portfolio
6.11.5 Chia Tai Tianqing Recent Developments
7 North America by Country
7.1 North America Frovatriptan Succinate Tablets Sales by Country
7.1.1 North America Frovatriptan Succinate Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Frovatriptan Succinate Tablets Sales by Country (2020-2025)
7.1.3 North America Frovatriptan Succinate Tablets Sales Forecast by Country (2026-2031)
7.2 North America Frovatriptan Succinate Tablets Market Size by Country
7.2.1 North America Frovatriptan Succinate Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Frovatriptan Succinate Tablets Market Size by Country (2020-2025)
7.2.3 North America Frovatriptan Succinate Tablets Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Frovatriptan Succinate Tablets Sales by Country
8.1.1 Europe Frovatriptan Succinate Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Frovatriptan Succinate Tablets Sales by Country (2020-2025)
8.1.3 Europe Frovatriptan Succinate Tablets Sales Forecast by Country (2026-2031)
8.2 Europe Frovatriptan Succinate Tablets Market Size by Country
8.2.1 Europe Frovatriptan Succinate Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Frovatriptan Succinate Tablets Market Size by Country (2020-2025)
8.2.3 Europe Frovatriptan Succinate Tablets Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Frovatriptan Succinate Tablets Sales by Country
9.1.1 Asia-Pacific Frovatriptan Succinate Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Frovatriptan Succinate Tablets Sales by Country (2020-2025)
9.1.3 Asia-Pacific Frovatriptan Succinate Tablets Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Frovatriptan Succinate Tablets Market Size by Country
9.2.1 Asia-Pacific Frovatriptan Succinate Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Frovatriptan Succinate Tablets Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Frovatriptan Succinate Tablets Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Frovatriptan Succinate Tablets Sales by Country
10.1.1 South America Frovatriptan Succinate Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Frovatriptan Succinate Tablets Sales by Country (2020-2025)
10.1.3 South America Frovatriptan Succinate Tablets Sales Forecast by Country (2026-2031)
10.2 South America Frovatriptan Succinate Tablets Market Size by Country
10.2.1 South America Frovatriptan Succinate Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Frovatriptan Succinate Tablets Market Size by Country (2020-2025)
10.2.3 South America Frovatriptan Succinate Tablets Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Frovatriptan Succinate Tablets Sales by Country
11.1.1 Middle East and Africa Frovatriptan Succinate Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Frovatriptan Succinate Tablets Sales by Country (2020-2025)
11.1.3 Middle East and Africa Frovatriptan Succinate Tablets Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Frovatriptan Succinate Tablets Market Size by Country
11.2.1 Middle East and Africa Frovatriptan Succinate Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Frovatriptan Succinate Tablets Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Frovatriptan Succinate Tablets Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Frovatriptan Succinate Tablets Value Chain Analysis
12.1.1 Frovatriptan Succinate Tablets Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Frovatriptan Succinate Tablets Production Mode & Process
12.2 Frovatriptan Succinate Tablets Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Frovatriptan Succinate Tablets Distributors
12.2.3 Frovatriptan Succinate Tablets Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.